An emphasis is placed on assessing the patients individual factors and engaging the patient prior to creation of a management plan
Eli Lillys December 2025 press release reported average weight loss of up to 71.2 lbs at the highest dose, alongside substantial relief from osteoarthritis pain
Novo Nordisk Inc., FDA approves Novo Nordisks Wegovy pill, the first and only oral GLP-1 for weight loss in adults (2025).
Roux-en-Y gastric bypass surgery changes fungal and bacterial microbiota in morbidly obese patients-A pilot study
Now, in this episode, were going to dive deep into the fascinating world of GLP 1 agonists
In vitro studies confirm that linagliptin suppresses the proliferation of several tumor cell lines, including colorectal cancer HCT116, breast cancer MCF-7, and liver cancer HepG2, via mechanisms that involve cell cycle arrest and apoptosis induction [96]